{"id":851943,"date":"2025-05-16T11:29:51","date_gmt":"2025-05-16T15:29:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/"},"modified":"2025-05-16T11:29:51","modified_gmt":"2025-05-16T15:29:51","slug":"lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/","title":{"rendered":"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, May  16, 2025  (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) for violations of the federal securities laws on behalf of investors who: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the \u201cClass Period\u201d) and thus were damaged by Defendants\u2019 violations of Section 10(b) of the Exchange Act (the \u201cFraud Claim Class\u201d); (b) held shares of Cerevel as of the January 8, 2024 record date (\u201cRecord Date\u201d) and were entitled to vote on the merger of Cerevel and AbbVie Inc. (\u201cAbbVie\u201d) and thus were damaged by Defendants\u2019 violations of Section 14(a) of the Exchange Act (the \u201cProxy Claim Class\u201d); and (c) sold shares of Cerevel stock contemporaneously with Bain Capital\u2019s purchase of shares on or about October 16, 2023 and thus were damaged by Bain\u2019s violations of Section 20A of the Exchange Act (the \u201cInsider Trading Claim Class,\u201d and collectively with the Fraud Claim Class and the Proxy Claim Class, the \u201cClass\u201d).<\/p>\n<p align=\"justify\">On April 3, 2025, a complaint was filed against the Company and its previously controlling shareholders (<em>i.e.<\/em>, Bain Capital Investors, LLC (\u201cBain\u201d) and Pfizer, Inc. (\u201cPfizer\u201d)), alleging that Cerevel\u2019s October 16, 2023 secondary stock offering (the \u201cOctober Offering\u201d or \u201cOffering\u201d) documents and other public statements omitted material facts regarding AbbVie\u2019s interest in acquiring Cerevel at a price well in excess of the $22.81 per share Offering price, artificially deflating Cerevel\u2019s stock price until the merger was announced. The complaint also alleges that Cerevel\u2019s controlling shareholder, Bain, acquired Cerevel shares from the October Offering at an artificially depressed price while allegedly in possession of material nonpublic information regarding AbbVie\u2019s interest.<\/p>\n<p align=\"justify\">On December 6, 2023 (less than two months after the October Offering), Cerevel publicly announced that AbbVie agreed to acquire Cerevel for $45 per share. The merger allowed Bain to receive a windfall of more than $120 million on the shares it acquired at the artificially depressed Offering price. As a result, Cerevel\u2019s investors were injured.<\/p>\n<p align=\"justify\">If you suffered a loss of more than $50,000 in Cerevel\u2019s securities, and wish to participate, or learn more, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QE6TDWREuTmCoYXoI0XYtHQc6KMNU8Fsm-uLGPVApY7XUiiQh9kdp5uwWIpmdDQ44IBE6186Hw46VtEvbZUP4gNTgoY8SYSRlijUcG2OLKs_ALG3hW_kNtCIjlWiba3K\" rel=\"nofollow\" target=\"_blank\"><u>click here<\/u><\/a>,\u00a0please contact our attorneys at (914) 733-7256 or via email to Andrea Farah (afarah@lowey.com) or Vincent R. Cappucci Jr. (vcappucci@lowey.com).<\/p>\n<p align=\"justify\">Any investor who wishes to serve as Lead Plaintiff must act before <strong>June 3, 2025<\/strong>.<\/p>\n<p align=\"justify\">\n        <strong>About Lowey Dannenberg<\/strong>\n      <\/p>\n<p align=\"justify\">Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has recovered billions of dollars on behalf of its clients.<\/p>\n<p align=\"justify\">\n        <strong>Contact<\/strong>:<\/p>\n<p>Lowey Dannenberg P.C.<br \/>44 South Broadway, Suite 1100<br \/>White Plains, NY 10601<br \/>Tel: (914) 733-7234<br \/>Email: afarah@lowey.com<\/p>\n<p>\n        <strong>SOURCE<\/strong>: Lowey Dannenberg P.C.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmY3ZTZiYmYtODVkZS00MDc4LWI0OWMtYWU5MmRjNjUwMzE4LTEyMDYwODctMjAyNS0wNS0xNi1lbg==\/tiny\/Lowey-Dannenberg-P-C-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) for violations of the federal securities laws on behalf of investors who: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the \u201cClass Period\u201d) and thus were damaged by Defendants\u2019 violations of Section 10(b) of the Exchange Act (the \u201cFraud Claim Class\u201d); (b) held shares of Cerevel as of the January 8, 2024 record date (\u201cRecord Date\u201d) and were entitled to vote on the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-851943","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) for violations of the federal securities laws on behalf of investors who: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the \u201cClass Period\u201d) and thus were damaged by Defendants\u2019 violations of Section 10(b) of the Exchange Act (the \u201cFraud Claim Class\u201d); (b) held shares of Cerevel as of the January 8, 2024 record date (\u201cRecord Date\u201d) and were entitled to vote on the &hellip; Continue reading &quot;Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-16T15:29:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm\",\"datePublished\":\"2025-05-16T15:29:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/\"},\"wordCount\":516,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/\",\"name\":\"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=\",\"datePublished\":\"2025-05-16T15:29:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/","og_locale":"en_US","og_type":"article","og_title":"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk","og_description":"NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) for violations of the federal securities laws on behalf of investors who: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the \u201cClass Period\u201d) and thus were damaged by Defendants\u2019 violations of Section 10(b) of the Exchange Act (the \u201cFraud Claim Class\u201d); (b) held shares of Cerevel as of the January 8, 2024 record date (\u201cRecord Date\u201d) and were entitled to vote on the &hellip; Continue reading \"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-16T15:29:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm","datePublished":"2025-05-16T15:29:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/"},"wordCount":516,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/","name":"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=","datePublished":"2025-05-16T15:29:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MzI0MSM2OTQ2NDUyIzIxOTQ1MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-cerevel-therapeutics-holdings-inc-cerevel-or-the-company-nasdaq-cere-investors-of-securities-class-action-lawsuit-and-encourages-in-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (\u201cCerevel\u201d or the \u201cCompany\u201d) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/851943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=851943"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/851943\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=851943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=851943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=851943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}